© Copyright 2005 New Hampshire Oncology-Hematology PA
1-800-339-6484
USO 05029 – Patients with recurrent cancer after receiving a first course of chemotherapy are eligible for this trial. Patients are treated with Abraxane, a new chemotherapy drug.
Home | Our Practice | Staff | Research | Helpful Information | Cancer Topics Education | Directions | Remembering a Loved One | Contact Us Privacy Statement | NHOH In The News | Disclaimer
Available Clinical Trials: Breast Cancer Colorectal Cancer Lung Cancer Prostate Cancer Gastric Cancer Pancreas Cancer Hodgkins Disease Bladder Cancer Kidney Cancer Blood Cancers Head and Neck Cancers Ovarian